Lab Procurement Peptide Documentation Checklist

Lab and industrial buyers need method-clear lot documents, a clean split between fixed catalog APIs and free-sequence custom work, and language that stays in RUO / industrial framing. This article is the full procurement checklist for research and industrial teams qualifying Peptisova.

It is not a clinic-dispense catalog, not a reconstitution calculator, and not consumer protocol content. Scenario hub: Research procurement. Category: Research APIs.

---

Who this checklist is for

If you need patient dosing protocols or clinic kits, see Compliance—we decline that framing.

---

Buyer pain points

• Need method-clear lot COAs (HPLC; MS when spec requires).
• Mix of fixed catalog APIs and free-sequence custom work.
• Must keep language in RUO / industrial—not clinic retail.
• May need building blocks (Fmoc) for in-house capacity.
• Must prevent reorder drift across multi-month programs.

---

Docs / RFQ checklist

1. Identity — catalog SKU or full sequence / modifications.
2. Purity target + format — vial vs powder (vials vs powder).
3. HPLC / MS requirements (Quality; HPLC/MS checklist; read a chromatogram).
4. Destination docs — list on RFQ.
5. Submit via Quote Cart with complete fields (RFQ fields guide).
6. Archive production lot IDs (batch numbers).
7. Cert hygiene — PDFs over adjectives (GMP-ready language).

COA literacy: What a peptide COA proves · COA vs full QA packet · COA Vault.

---

Buyer decision framework

1. Is the need met by a fixed catalog API on Track A, or is it custom Track B?
2. What analytical bar does your SOP require—HPLC only, or MS too?
3. Will receiving staff reconcile lot IDs on day one?
4. Are all stakeholders aligned on RUO / industrial language?
5. Have you scored ownership vs reseller risk (verify hub; alternatives checklist)?

Skipping step 4 is how RFQs accidentally request dosing content and stall.

---

Catalog vs custom vs building blocks

Example catalog APIs teams often qualify: LL-37 5 mg (buyer guide), Argipressin acetate, Gonadorelin acetate, Somatostatin-14, Thymosin alpha-1.

---

QC questions lab procurement should ask

• Which methods appear on the lot COA for this SKU family?
• Can MS be included when our SOP requires identity confirmation?
• Who investigates OOS HPLC, and can QA speak to them directly?
• Will each new lot ship with its own COA—not a recycled sample PDF?
• Confirm RUO / industrial only—no reconstitution calculator merchandising?

Ownership narrative: manufacturer vs reseller · Fact Sheet.

---

Procurement workflow sketch (first PO cycle)

1. Align internal language on RUO / industrial (Compliance).
2. Choose catalog vs custom; open the relevant PDP or custom hub.
3. Train receiving on COA shape via COA Vault.
4. Place Track A PO or complete RFQ on Quote Cart.
5. Match lot IDs on receipt; archive before scheduling reorder.
6. Only change purity/format/methods through an intentional new qualification.

---

Deeper scenario notes for lab / industrial buyers

Multi-site companies should decide whether receiving is centralized. If site A archives lot COAs and site B reorders blindly, you will recreate drift even with a good manufacturer. Share the tracker template, not only the first PDF.

Custom synthesis RFQs fail most often on incomplete fields: missing modifications, unclear purity target, or “MS if possible” without saying whether it is required. Use the RFQ fields guide as a gate before sales time is spent.

When your program mixes catalog APIs and in-house synthesis, keep purchase orders labeled clearly so finance and QA do not treat Fmoc starters as finished peptide APIs. The Fmoc starter pack is a building-block path; catalog vials like LL-37 5 mg are finished research APIs with their own lot files.

If a supplier answers analytical questions with lifestyle merchandising or dosing calculators, stop—regardless of purity adjectives (Compliance; alternatives checklist).

---

What this page is NOT

This checklist is not:

• Dosing or reconstitution protocols
• Clinic-dispense onboarding
• Melanotan / performance stack merchandising
• A claim that COAs prove clinical efficacy
• Consumer retail guidance

Explicit declines: no reconstitution calculators, Melanotan, performance stacks, consumer retail (Compliance).

---

RFQ stub (lab / industrial)

> Lab procurement RFQ: catalog SKU ___ or sequence/mods ___; qty ___; format [vial/powder]; purity target ___; HPLC [yes]; MS [required/not]; destination docs ___; prior lot IDs ___; target ship window ___; RUO/industrial confirmation [yes].

Submit via Quote Cart.

---

A short internal SLA helps: “No receiving close without lot ID match” and “No reorder without archived prior COA.” Those two rules prevent most silent drift without adding heavy software. Pair them with Quality contacts on speed-of-answer for OOS questions, and keep custom vs catalog clearly labeled in your ERP notes so auditors can follow the path from RFQ to lot file without reconstructing chat history. When in doubt, open a new qualification rather than hoping “same SKU” still means the same specification.

For program-level diligence across vendors, keep the same scorecard columns you would use for any peptide manufacturer—ownership, documents, commerce honesty, and compliance—so lab convenience never overrides analytical accountability.

Related reading

• LL-37 manufacturer buyer guide
• HPLC/MS QC checklist
• What a peptide COA proves
• RFQ fields that speed custom quotes
• GMP-ready language
• Research procurement hub · Quote

---

Next step

Open Research APIs or Custom peptide synthesis, review COA Vault, then place a Track A order or structured RFQ via Quote Cart.

Peptisova supplies research and industrial peptide APIs with documentation for B2B procurement—not consumer or clinic-dispense programs.